Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Acta Neuropathologica|May 8, 2019
RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomasPeter Wirthschaft, Julia Bode, Himanshu Soni, et al.Theranostics|April 17, 2026
Voxel-accurate MRI-microscopy Correlation Enables AI-powered Prediction of Brain Disease StatesJulian Schroers, Yvonne Yang, Ekin Reyhan, et al.Neuro-Oncology|May 28, 2021
Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse modelMilena Simovic, Michiel Bolkestein, Mahmoud Moustafa, et al.Nature Metabolism|July 10, 2023
Targeting the TCA cycle can ameliorate widespread axonal energy deficiency in neuroinflammatory lesionsYi-Heng Tai, Daniel Engels, Giuseppe Locatelli, et al.Nature Cancer|July 1, 2026
IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trialLukas Bunse, Katharina Lindner, Antje Wick, et al.International Journal of Cancer|March 28, 2018
A PRDX1-p38α heterodimer amplifies MET-driven invasion of IDH-wildtype and IDH-mutant gliomasPeter Wirthschaft, Julia Bode, Anika E M Simon, et al.Scientific Reports|July 6, 2024
Tumor biomechanics as a novel imaging biomarker to assess response to immunotherapy in a murine glioma modelYannik Streibel, Michael O Breckwoldt, Jessica Hunger, et al.Journal of Neurointerventional Surgery|August 1, 2023
MR microscopy to assess clot composition following mechanical thrombectomy predicts recanalization and clinical outcomeKianush Karimian-Jazi, Dominik F Vollherbst, Daniel Schwarz, et al.Nature Medicine|September 22, 2023
A H3K27M-targeted vaccine in adults with diffuse midline gliomaNiklas Grassl, Isabel Poschke, Katharina Lindner, et al.Nature|March 25, 2021
A vaccine targeting mutant IDH1 in newly diagnosed gliomaMichael Platten, Lukas Bunse, Antje Wick, et al.Pageof 7